K. N. Verpoort

Antibodies to citrullinated proteins and differences in clinical progression of rheumatoid arthritis

Annette H M van der Helm–van Mil, K. N. Verpoort, Ferdinand C. Breedveld et al. · Arthritis Research & Therapy · 2005 · 482 citations · Full text

Life Sciences, Immunology, Internal Medicine +13

The HLA–DRB1 shared epitope alleles are primarily a risk factor for anti–cyclic citrullinated peptide antibodies and are not an independent risk factor for development of rheumatoid arthritis

Annette H M van der Helm–van Mil, K. N. Verpoort, Ferdinand C. Breedveld et al. · Arthritis & Rheumatism · 2006 · 349 citations

Life Sciences, Immunology, Internal Medicine +15

Epitope spreading of the anti-citrullinated protein antibody response occurs before disease onset and is associated with the disease course of early arthritis

Diane van der Woude, Solbritt Rantapää‐Dahlqvist, A. Ioan-Facsinay et al. · Annals of the Rheumatic Diseases · 2010 · 318 citations

Life Sciences, Immunology, Internal Medicine +17

Isotype distribution of ANTI–CYCLIC citrullinated peptide antibodies in undifferentiated arthritis and rheumatoid arthritis reflects an ongoing immune response

K. N. Verpoort, Cornelia M. Jol‐van der Zijde, Ellen A. M. Papendrecht-van der Voort et al. · Arthritis & Rheumatism · 2006 · 212 citations

Life Sciences, Immunology, Internal Medicine +15

Association of HLA–DR3 with anti–cyclic citrullinated peptide antibody–negative rheumatoid arthritis

K. N. Verpoort, Floris A. van Gaalen, Annette H M van der Helm–van Mil et al. · Arthritis & Rheumatism · 2005 · 176 citations

Life Sciences, Genetics, Immunology +17